TPOXX® Antiviral Treatment (Tecovirimat)
The monkeypox virus belongs to a family of viruses called orthopox viruses and the drug Tecovirimat is an antiviral designed specifically to treat viral infections of this kind. In the current outbreak, Tecovirimat has been successfully used to treat patients with the most severe presentations of monkeypox virus infection. This contract is for a small supply of TPOXX® Antiviral Treatment (Tecovirimat) for the treatment of severe cases of Monkeypox in the UK.
Buyer
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Value
Not provided
Published
3 Nov 2022
Closes
3 Nov 2022
Procurement details
Source
Find a Tender
Region
Tower Hamlets
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33651400
Antivirals for systemic use
Lots
Lot 1 TPOXX® Antiviral Treatment (Tecovirimat)
Value not provided
Supply of Tecovirimat antiviral treatment
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.